# Miyoshi America, Inc – FDA Inspection, Jan 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/miyoshi-america-inc/3da6d54d-300a-4547-9433-a29e7c20d217
Source feed: FDA_Inspections

> FDA inspection 1198326 of Miyoshi America, Inc, January 13, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198326
- Company Name: Miyoshi America, Inc
- Inspection Date: 2023-01-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1306728 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/miyoshi-america-inc/ac1adf18-2faf-4a07-8280-d7e05f2e174a)
- [FDA Inspection 1144549 - 2021-05-25](https://www.keypedia.com/records/fda_inspections/miyoshi-america-inc/2a38b802-d721-4010-afa3-2e555ecdbfe0)
- FDA Inspection 974319 - 2016-06-03
- FDA Inspection 950532 - 2015-11-17
- [FDA Inspection 737348 - 2011-07-20](https://www.keypedia.com/records/fda_inspections/miyoshi-america-inc/37d58ace-8951-4ef2-bb00-594b95adbcbc)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)
- [FDA Associated Person](https://www.keypedia.com/people/samir-c-gala/904c34ee-013d-4663-a87a-9cbdbcf2b40e)

Company: https://www.keypedia.com/companies/miyoshi-america-inc/b8b68045-2f79-4dab-a8b0-08e43de931cb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c